Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3
2(66.7%)
Phase 2
1(33.3%)
3Total
Phase 3(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT05982847Recruiting

National Blood Pressure Screening in Children to Improve Paediatric Healthcare in South Africa

Role: collaborator

NCT04794660Phase 3Active Not Recruiting

The Study for the "Cervical Cancer Screening and Treatment Algorithms Study Using HPV Testing in Africa"

Role: collaborator

NCT04709302Unknown

Effects of COVID-19 on Endothelium in HIV-Positive Patients in Sub-Saharan Africa

Role: collaborator

NCT05091827Unknown

Cardiovascular Risk in Infants Exposed to Pre-eclampsia in Utero

Role: lead

NCT02454205Phase 2Completed

An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis

Role: collaborator

NCT04763668Unknown

Cardiometabolic Health of Children Exposed to Anti-retroviral Therapy (ART) in Utero

Role: lead

NCT02673879Phase 3Unknown

IMPI 2 - A Trial of Intrapericardial Alteplase in Large Pericardial Effusion

Role: collaborator

All 7 trials loaded